Hill Lab (@Geoff_Hill_Lab) header
Hill Lab (@Geoff_Hill_Lab) profile picture

Hill Lab (run by lab members) @FredHutch #BMT #GVHD #immunotherapy #myeloma

Fred Hutchinson
Joined February 2020
Photo by Hill Lab (@Geoff_Hill_Lab)Photo by Hill Lab (@Geoff_Hill_Lab)
Eomes controls the acquisition of regulatory and cytotoxic function in CD4+ T cells that are critical for limiting immune toxicity, while maintaining persistence and tumor control after immunotherapy @ImmunityCP cell.com/immunity/fulltext/S… @fredhutch @Geoff_Hill_Lab 🇺🇸
6
19
1,124
I’m excited to share what has been 5 years in the making (my first project in the lab starting as a heme/onc fellow)! Microbiota dictate T cell clonal selection to augment graft-vs-host-disease following stem cell transplant. @ImmunityCP @Geoff_Hill_Lab cell.com/immunity/fulltext/S…
3
13
1
38
8,763
Treg depletion during SCM expands polyfunctional effector T cells in mobilized grafts and enhances antimyeloma immunity after ASCT. ow.ly/syjV50RjakL #transplantation #immunobiologyandimmunotherapy
9
14
3,462
For open access to our recent manuscript describing T cells that retained functional capacity despite a terminally exhausted phenotype, visit the Hill Lab webpage via the link below and scroll down to the myeloma section! research.fredhutch.org/geoff…
1
6
818
When the autograft team hears the boss has a penchant for band T-shirts…. – at Seattle, WA
1
7
684
Agonist #immunotherapy with engineered IL-18 following allogeneic bone marrow transplant in mice improved anti-tumor activity without increasing the chance of graft-versus-host onset. @fredhutch @MonashUni @simone_minnie @Geoff_Hill_Lab scim.ag/bY
CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplant loom.ly/0EL7W_E
1
15
49
Still time to apply! The Hill lab is looking for a postdoc to work on Immunotherapy/CAR T cell projects. Message me if you have any Q's about working in the lab etc. FHCRC has great visa support as well! social.icims.com/viewjob/pt1…
1
4
4
I’ll be presenting two of our #immunotherapy for #myeloma projects. One oral presentation on the combination of TIGIT and lenalidomide (Sat 4:45pm) and a poster on an IL-2/IL-15 mimetic (NL201) on Sat as well!
#ASH21 abstracts are now live! Click here: loom.ly/U7wx2-w What abstracts are you most excited about? 🤩 Tells us via quote retweets or replies!
1
1
9
Outstanding talk about T cell differentiation and exhaustion of myeloma specific T cells in murine models. By @simone_minnie of Geoff Hill’s lab at @fredhutch at @RHsct2. – at Manhattan, NY
This Post is from an account that no longer exists. Learn more
Fred Hutch's #Immunotherapy Integrated Research Center (IIRC) is accepting applications for a faculty position in #cancer #immunology. Learn more and apply: apply.interfolio.com/94679 #CareersStartHere @FH_IRC
1
6
CMV exposure in SCT donors leaves a lasting immunological impression. @AlbertCYeh & @Geoff_Hill_Lab, Clinical Research Division @fredhutch, find new links between a CMV-specific memory CD4+ T cell subset and poor stem cell transplant outcomes. Read more: fredhutch.org/en/news/spotli…
5
7
Now recruiting members of my new lab! Excited to build a team at the Fred Hutch, starting this fall. #microbiome #BMT #immunology social.icims.com/viewjob/pt1…
10
37
8
82
Check out this latest podcast with @ASH_hematology where we discuss the importance of gut microbes in allogeneic bone marrow transplantation together with Dr Jonathan Peled #mskcc @DrMvandenBrink @NEJM @BloodJournal soundcloud.com/ash_hematolog…
4
5
Replying to @simone_minnie
@simone_minnie describing TIGIT as an excellent target post autoHCT in #myeloma #TCTM20